Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART
Titel:
Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART
Auteur:
Palacios, R. Pérez-Hernández, I. A. Martínez, M. A. Mayorga, M. L. González-Domenech, C. M. Omar, M. Olalla, J. Romero, A. Romero, J. M. Pérez-Camacho, I. Hernández-Quero, J. Santos, J.
Verschenen in:
European journal of clinical microbiology & infectious diseases